SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-14-011921
Filing Date
2014-06-26
Accepted
2014-06-26 17:36:39
Documents
1
Period of Report
2014-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 10140
  Complete submission text file 0001437749-14-011921.txt   11654
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Patel Sailash (Reporting) CIK: 0001590795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 14943587